Suppr超能文献

袖状切除术在晚期淋巴结疾病中的作用。

The role of sleeve resections in advanced nodal disease.

机构信息

Department of Thoracic Surgery, Dr. -Horst-Schmidt-Klinik, Wiesbaden, Germany.

出版信息

Eur J Cardiothorac Surg. 2011 Nov;40(5):1157-63. doi: 10.1016/j.ejcts.2011.02.037. Epub 2011 Mar 31.

Abstract

OBJECTIVE

The aim of this study was to compare the short-term and long-term results of sleeve resections depending on limited nodal disease (N0/N1, LND) and advanced nodal disease (N2/N3, AND) for non-small cell lung cancer (NSCLC) at a single institution.

METHODS

We retrospectively reviewed our prospective database of all NSCLC patients undergoing sleeve resections between January 1999 and December 2008. Patients' characteristics, morbidity, mortality, locoregional recurrence, distant recurrence, and survival were analyzed corresponding to LND and AND.

RESULTS

The indication was NSCLC for 170 sleeve resections (LND: n=120; AND: n=50) out of 213 consecutive sleeve resections. Both groups were statistically equal with regard to age (LND 61.8±12.4 vs AND 60.8±9.6 years), gender, co-morbidities, type of sleeve resection (bronchial vs bronchovascular), number of dissected lymph nodes (LND 40.0±12.4 vs AND 36.7±14.0), histology and completeness of resection (LND 96.7% vs AND 98.0%), respectively. More patients had induction chemotherapy in AND group (p=0.049). The short-term results were equal on the subject of morbidity rate (LND: 34.2%, AND: 44.0%), secondary pneumonectomy (LND: 1.7%, AND: 4.0%), and mortality rate (LND: 5.0%, AND: 6.0%), respectively. LND was associated with a better 5-year-survival rate (LND: 67%; AND: 42%) and mean survival (LND: 80.8 months; AND: 37.7 months; p=0.014). In the long-term follow-up, more distant metastases were detected in AND group (26.0% vs 14.2%, p=0.079) in contrast to identical locoregional recurrence (LND: 1.7%; AND: 0%). In the event of metastazing, the mean time to the development of distant metastases was similar (LND: 19.1 months; AND: 12.4 months; p=0.2).

CONCLUSIONS

Lymph node involvement is a negative prognostic factor concerning long-term survival. Sleeve resections in AND do not result in higher morbidity and mortality. But even in AND, sleeve resections are associated with promising long-term survival and extraordinary local control of the disease as a result of high complete resection rates. High rate of distant failure warrants further investigation for the systemic control of the disease.

摘要

目的

本研究旨在比较单中心非小细胞肺癌(NSCLC)患者因局限性淋巴结疾病(N0/N1,LND)和进展性淋巴结疾病(N2/N3,AND)行袖状切除术的短期和长期结果。

方法

我们回顾性分析了 1999 年 1 月至 2008 年 12 月期间在我们机构行袖状切除术的所有 NSCLC 患者的前瞻性数据库。根据 LND 和 AND 分析患者特征、发病率、死亡率、局部区域复发、远处复发和生存率。

结果

213 例连续行袖状切除术患者中,170 例行袖状切除术(LND:n=120;AND:n=50)。两组在年龄(LND:61.8±12.4 岁 vs AND:60.8±9.6 岁)、性别、合并症、袖状切除类型(支气管 vs 支气管血管)、淋巴结清扫数目(LND:40.0±12.4 个 vs AND:36.7±14.0 个)、组织学和切除完整性(LND:96.7% vs AND:98.0%)方面均无统计学差异。AND 组有更多的患者接受了诱导化疗(p=0.049)。两组的短期结果在发病率(LND:34.2%,AND:44.0%)、二次全肺切除术(LND:1.7%,AND:4.0%)和死亡率(LND:5.0%,AND:6.0%)方面无统计学差异。LND 与 5 年生存率(LND:67%;AND:42%)和平均生存时间(LND:80.8 个月;AND:37.7 个月;p=0.014)的改善相关。在长期随访中,AND 组远处转移的发生率更高(26.0% vs 14.2%,p=0.079),而局部区域复发率相似(LND:1.7%;AND:0%)。发生转移时,远处转移的平均时间相似(LND:19.1 个月;AND:12.4 个月;p=0.2)。

结论

淋巴结受累是影响长期生存的预后不良因素。AND 中袖状切除术不会导致更高的发病率和死亡率。但即使在 AND 中,袖状切除术也与有希望的长期生存和疾病的高完全切除率相关的出色局部控制相关。远处失败率较高需要进一步研究疾病的全身控制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验